Verbena Officinalis Homeopathic Pills Fail Identification Testing
Washington Homeopathic Products is recalling 3 bottles of Verbena Officinalis 6X (Lot #29060, expiration 8/17/2026) distributed nationwide due to out-of-specification test results in identification testing.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. No illnesses, injuries, or deaths are reported in the source text. The defect (out-of-specification identification testing) is a quality-control issue without documented harm, qualifying this as a moderate precautionary recall.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling 3 bottles of Verbena Officinalis 6X, Nervousness* Sucrose/Lactose Pills, Packaged 2 Dram (WHP Homeopathic Medicine) due to out-of-specification test results obtained during identification testing based on HPTLC analysis.
The affected product is Lot #29060 with expiration date 8/17/2026. The product was distributed nationwide in the USA.
The manufacturer has identified that the product failed identification testing, indicating that the product composition or purity does not meet specifications. Consumers who have purchased this product should discontinue use and consult with a healthcare provider or the manufacturer for guidance on next steps.
The recalled product
- Product
- Verbena Officinalis 6X, Nervousness* Sucrose/Lactose Pills, Packaged 2 Dram, WHP Homeopathic Medicine, Washington Hoemopathis Producs, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29060
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Washington Homeopathic Products, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same manufacturer · Washington Homeopathic Products, Inc.
See all →- LowHomeopathic Kit Recalled for Label Mix-up Between Products
FDA (Drugs) · 2024-07-31
- ModerateHomeopathic Drug Recall: Vaccinotoxinum Products Due to Manufacturing Violations
FDA (Drugs) · 2022-06-22
- ModerateDrug recall: Tuberculinum Bovinum due to manufacturing practice deviations
FDA (Drugs) · 2022-06-22
- ModeratePyrogenium Homeopathic Remedy Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Colibacillinum Drug Recall Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
Same hazard · specification failure
See all →- ModerateZeiss Intrabeam Spherical Applicator failed manufacturing specifications
FDA (Devices) · 2026-07-08
- HighSkin cancer aid recalled because it may not meet specifications
FDA (Devices) · 2025-12-03
- CriticalPericardial patches recalled because a lot may not meet tensile strength
FDA (Devices) · 2025-12-03
- CriticalSmaller pericardial patches recalled over a tensile strength specification failure
FDA (Devices) · 2025-12-03
- Low
Similar recalls
- HighWashington Homeopathic Products Recalls Silicea 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Products Recalls Kali Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27
- ModerateHomeopathic Drug Pertussinum Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2022-06-22
- ModerateHomeopathic Drug Anthracinum Recalled Over Manufacturing Compliance Deviations
FDA (Drugs) · 2022-06-22
- ModerateWashington Homeopathic Products Recalls R2103 Due to Manufacturing Deviations
FDA (Drugs) · 2019-11-27
- ModerateWashington Homeopathic Recalls Natrum Sulphuricum 6X Tablets for CGMP Deviations
FDA (Drugs) · 2019-11-27